scholarly journals Application of ensemble Pharmacophore-Based Virtual Screening to the discovery of novel antimitotic tubulin inhibitors

Author(s):  
Laura Gallego-Yerga ◽  
Rodrigo Ochoa ◽  
Isaías Lans ◽  
Carlos Peña-Varas ◽  
Melissa Alegría-Arcos ◽  
...  
2010 ◽  
Vol 18 (19) ◽  
pp. 7092-7100 ◽  
Author(s):  
Nam Doo Kim ◽  
Eun-Sook Park ◽  
Young Hoon Kim ◽  
Seung Kee Moon ◽  
Sung Sook Lee ◽  
...  

Author(s):  
P. A. Karpov ◽  
O. M. Demchuk ◽  
S. P. Ozheriedov ◽  
S. I. Spivak ◽  
O. V. Raievskyi ◽  
...  

Aim. Implementation of 3D-modeling, molecular dynamics, high-throughput screening and molecular docking for search of new inhibitors of parasitic fungi tubulin. Methods. Protein structures were constructed using I-TASSER server and optimized by Gromacs. Ligands library was prepared in Mopac7 program and screened using UCSF Dock 6. Best ligands were docked in CCDC Gold. Results. It was reconstructed spatial molecular structure for 93 α-, 95 β- and 78 γ-tubulins from 76 species of pathogenic fungi genus: Microsporum, Arthroderma, Histoplasma, Blastomyces, Emmonsia, Uncinocarpus, Coccidioides, Paracoccidioides, Aspergillus, Botrytis cinerea, Sclerotinia, Rhynchosporium, Marssonina, Scedosporium, Fusarium, Gibberella, Candida, Ceraceosorus, Malassezia, Anthracocystis, Melanopsichium, Sporisorium, Ustilago, Cryptococcus, Trichosporon, Mucor, Rhizopus and Lichtheimia. Libraries of 3D-models of parasitic fungi tubulins and perspective ligands were created. Based on results of high-throughput virtual screening, 200 perspective agents were selected from more than 7 million compounds. After resulting molecular docking in CCDC GOLD, we specify 19 leading compounds. We propose these compounds as potent tubulin inhibitors and recommend them for in vitro testing as new fungicides. Conclusions. Based on results of high-throughput virtual screening in Grid, 19 new imidazole inhibitors of parasitic fungi tubulin were selected.Keywords: microtubule, tubulins, fungicides, imidazole derivatives, virtual screening, molecular docking.


2012 ◽  
Vol 52 (10) ◽  
pp. 2730-2740 ◽  
Author(s):  
Ran Cao ◽  
Minyu Liu ◽  
Min Yin ◽  
Quanhai Liu ◽  
Yanli Wang ◽  
...  

2009 ◽  
Vol 52 (14) ◽  
pp. 4221-4233 ◽  
Author(s):  
Yi-Kun Chiang ◽  
Ching-Chuan Kuo ◽  
Yu-Shan Wu ◽  
Chung-Tong Chen ◽  
Mohane Selvaraj Coumar ◽  
...  

Molecules ◽  
2019 ◽  
Vol 24 (17) ◽  
pp. 3181
Author(s):  
Yunjiang Zhou ◽  
Bin Di ◽  
Miao-Miao Niu

Tubulin inhibitors have been considered as potential drugs for cancer therapy. However, their drug resistance and serious side-effects are the main reasons for clinical treatment failure. Therefore, there is still an urgent need to develop effective therapeutic drugs. Herein, a structure-based pharmacophore model was developed based on the co-crystallized structures of the tubulin with a high resolution. The model including one hydrogen-bond acceptor feature, two aromatic features, and one hydrophobic feature was further validated using the Gunner–Henry score method. Virtual screening was performed by an integrated protocol that combines drug-likeness analysis, pharmacophore mapping, and molecular docking approaches. Finally, five hits were selected for biological evaluation. The results indicated that all these hits at the concentration of 40 μM showed an inhibition of more than 50% against five human tumor cells (MCF-7, U87MG, HCT-116, MDA-MB-231, and HepG2). Particularly, hit 1 effectively inhibited the proliferation of these tumor cells, with inhibition rates of more than 80%. The results of tubulin polymerization and colchicine-site competition assays suggested that hit 1 significantly inhibited tubulin polymerization by binding to the colchicine site. Thus, hit 1 could be used as a potential chemotherapeutic agent for cancer treatment. This work also demonstrated the potential of our screening protocol to identify biologically active compounds.


Sign in / Sign up

Export Citation Format

Share Document